FRC schreef op 29 oktober 2016 10:36:
Een blik op Esperite in de laatste 2 twee jaar, die goed op weg is verbeteren van kwaliteit van gezondheidszorg technologie:
Zo is het begonnen: In line with its continuous efforts to improve internal stem cell procedures, Cryo-Save proudly announces the appointment of the highly knowledgeable stem cell expert
Dr. Marcin Jurga April 24, 2012, Na de komst van Marcin Jurga en de persberichten over de pipelines die volgen:
1) GMP stem cell bioproduction technology and aims the
cerebral palsy as first clinical trial.
25 September 20141A) investigation of new treatment of
Cerebral Palsy using dual infusion of two types of stem cells derived from umbilical cord blood and cord tissue processed by CryoSave.
23 February 20152 )Development of more effective and accessible therapies for a broad spectrum of inflammatory and autoimmune diseases including
type 1 diabetes, arthritis and multiple sclerosis Zutphen, The Netherlands –
17 August 20153 )EVs application in untreatable-yet acute and chronic drug-resistant
epilepsy in children. Zutphen, The Netherlands –
30 September 20164) Therapies for inflammatory bowel disease (IBD) using extracellular vesicles (EVs). The first target is
[i] Crohn’s disease[/i] perianal fistulas in adults. A first in man study using EVs including exosomes for treatment of Croh
n’s disease perianal fistula will start in 2017.
20 October 2016wat Genoma betreft:
1) ESPERITE tackles
Autism with revolutionary Genetic test.
February 5, 2015 REALITY, a predictive genetic test uncovering the predisposition of children to autism.
1A) ESPERITE acquires InKaryo, US start-up specialised in Bioinformatics for genetic diagnostics and molecular cytogenetic tests.
March 19, 20152) ESPERITE validates SERENITY, the breast and ovarian cancer risk screening test that sequences the entire BRCA1 and BRCA2 genes and detects all variants.
April 14, 20153) Esperite’s GENOMA jointly with Catholic University of the Sacred Heart’s FONDAZIONE GIOVANNI PAOLO II and MOLIPHARMA will develop NGS-based tests in Italy and project new diagnotics
4) Genoma consolidates its position in Europe expanding its Genetic Cloud and Network in Italy and establishing its genetic Center of Excellence for Italy. Improving the access of the population to predictive medicine technologies, and offering from the onset Genoma’s genetic tests to its patients.
20 August 20154AGenoma sales increased by 171% compared to the same period last year and 58% compared to the HY2 2015.
23 August 2016--------------------------
Een korte periode met belovende stappen..
Fijn weekend.